Literature DB >> 15520503

Cytotoxic and proapoptotic effects of new Pd(II) and Pt(II)-complexes with 3-ethanimidoyl-2-methoxy-2H-1,2-benzoxaphosphinin-4-ol-2-oxide.

Elzbieta Budzisz1, Urszula Krajewska, Marek Rózalski.   

Abstract

The new palladium (II) and platinum (II) complexes 2 and 3 with 3-ethanimidoyl-2-methoxy-2H-1,2-benzoxaphospinin-4-ol-2-oxide 1 were synthesized and their physicochemical and pharmacological properties were determined. The cytotoxic effects of these complexes were examined on the two human leukemia cell lines, HL-60 and NALM-6. Pd-complex 2 and Pt-complex 3 exerted significant cytotoxic activity. The effects exhibited by these two complexes were comparable to those reported for cis-platin and carboplatin. On the other hand, ligand 1 was not cytotoxic. As determined by caspase-3 activity assay, compounds 2 and 3 differed slightly in their mode of induction of the programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520503

Source DB:  PubMed          Journal:  Pol J Pharmacol        ISSN: 1230-6002


  3 in total

1.  Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro.

Authors:  Engin Ulukaya; Ferda Ari; Konstantinos Dimas; Mehmet Sarimahmut; Emel Guney; Nikos Sakellaridis; Veysel T Yilmaz
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-02       Impact factor: 4.553

2.  Anticancer and antimicrobial properties of novel η6-p-cymene ruthenium(ii) complexes containing a N,S-type ligand, their structural and theoretical characterization.

Authors:  Ewelina Namiecińska; Beata Sadowska; Marzena Więckowska-Szakiel; Anna Dołęga; Beata Pasternak; Magdalena Grazul; Elzbieta Budzisz
Journal:  RSC Adv       Date:  2019-11-27       Impact factor: 4.036

3.  Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells.

Authors:  Engin Ulukaya; Fiona M Frame; Buse Cevatemre; Davide Pellacani; Hannah Walker; Vincent M Mann; Matthew S Simms; Michael J Stower; Veysel T Yilmaz; Norman J Maitland
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.